Clinical Trial Update: Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update of pazopanib in advanced and cisplatin-resistant germ cell tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumors

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Germ Cell Tumors, Measurable Disease | Phase 2 | Status: COMPLETED